ESMO 2022 curated collection – GU cancers

Thursday, 17 Nov 2022


Watch again as experts present their highlights in GU cancers from this year’s ESMO meeting and discuss how they may impact practice:

  1. Game Changers in GU cancers
  2. Adjuvant therapy updates in renal cell cancer – feat. IMmotion-010, PROSPER, KN-564, CM-914
  3. Highlights in metastatic renal cell cancer – feat. COSMIC-313,  CLEAR, SWOG 1500
  4. Highlights in bladder cancer- feat. EV-103 Cohort K
  5. Highlights in prostate and testicular cancer – feat. RADICALS-HD, DADSPORT, PRESTO

Game Changers in GU cancers

Adjuvant therapy updates in renal cell cancer

Highlights in metastatic renal cell cancer

Highlights in bladder cancer

Highlights in prostate and testicular cancer

These events were supported by unrestricted educational grants and created independently by the limbic in collaboration with the hosts and panels. All studies were selected by the panels and all views expressed are those of the hosts and panels only.

Already a member?

Login to keep reading.

OR
Email me a login link
logo

© 2023 the limbic